Text Size

Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication

Uusitalo H., Chen E., Pfeiffer N., Brignole-Baudouin F., Kaarniranta K., Leino M., Puska P., Palmgren E., Hamacher T., Hofmann G., Petzold G., Richter U., Riedel T., Winter M., Ropo A.

  • 2010
  • Acta Ophthalmologica
View publication
  • Therapeutic Area


  • Categories

    Clinical development

  • Affiliations

    University of Tampere, Tampere University Hospital, Tampere, Finland; St Erik Eye Hospital, Stockholm, Sweden; Augenklinik der Joh.-Gutenberg- Universität Mainz, Mainz, Germany; Department of Toxicology, University Paris Descartes, University Paris 6, Paris, France; University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland; Kuopion Näkökeskus, Kuopio, Finland; Helsingin Lääkärikeskus, Helsinki, Finland; Nyköpings Lasarett, Nyköping, Sweden; Praxis Starnberg, Starnberg, Germany; Praxis Schweinfurt, Schweinfurt, Germany; Praxis Kulmbach, Kulmbach, Germany; Praxis Regensburg, Regensburg, Germany; Praxis Dresden, Dresden, Germany; Praxis Bremen, Bremen, Germany; Santen Oy, Tampere, Finland

Related Publications

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 2-year Results from a Randomized, Multicenter Study

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Khatana AK, Lee B, Nguyen T, Stiles MC, Sadruddin O, Khaw PT.

Omidenepag Isopropyl in Latanoprost Low/Non-Responders with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3, Non-Randomized, Two-Phase, Open-Label Study

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A.

The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022